Ron Alfa is Vice President of Discovery & Product at Recursion. In his role, Ron leads Product across Discovery Biology, Data Science, and Engineering, working closely with teams to execute on Recursion’s vision of reimagining drug discovery through AI. Prior to Recursion, Ron cut his teeth on startups at the Stanford-affiliated accelerator StartX. In his academic career, he has developed molecular therapeutics for Alzheimer’s disease, discovered metabolic hormones, and puzzled over the basis of the placebo effect. He holds a BS in Animal Physiology & Neurosciences from UCSD, an MA in History of Medicine from University College London, and a PhD in Neurosciences and MD from Stanford University School of Medicine. Ron is a first-generation college graduate, and recipient of the prestigious Paul & Daisy Soros Fellowship for New Americans.
Ron Alfa
